Who owns GANX?
Institutional ownership of Gain Therapeutics Inc. from Form 13F, Q2 2026
50 institutional managers reported holding Gain Therapeutics Inc. (GANX) in Form 13F filings for Q2 2026, with 9,229,420 shares worth $18.6M. The largest reported holder was Marshall Wace, LLP. Managers that filed both quarters added a net 1,034,421 shares (+12.6%). 12 opened new positions and 4 sold out.
- Funds holding
- 50
- Value held
- $18.6M
- New / sold out
- 12 / 4
- Net shares, same filers
- +12.6%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of GANX
Share of 13F holdings is each fund's shares as a share of the 9,229,420 GANX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Cambridge Investment Research Advisors, Inc. Added+$1.2M
- Gsa Capital Partners LLP Added+$649K
- Marshall Wace, LLP Added+$312K
- Squarepoint Ops LLC New+$277K
- Citadel Advisors LLC Added+$263K
- Vanguard Capital Management LLC Added+$163K
- Stratos Wealth Partners, LTD. Added+$139K
- XTX Topco Ltd New+$112K
- BlackRock, Inc. Added+$101K
- Commonwealth Equity Services, LLC Added+$58K
Biggest sellers in Q2 2026
- Susquehanna International Group, LLP Trimmed-$717K
- Jane Street Group, LLC Trimmed-$327K
- Potomac Capital Management, Inc. Trimmed-$126K
- Schonfeld Strategic Advisors LLC Sold out-$48K
- Jones Financial Companies LLLP Trimmed-$40K
- Northern Trust Corp Trimmed-$34K
- Morgan Stanley Trimmed-$28K
- Simplex Trading, LLC Sold out-$26K
- Kestra Advisory Services, LLC Sold out-$23K
- UBS Group AG Trimmed-$11K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $3.5M and sold $1.4M; 15 added and 9 trimmed.
Questions about GANX ownership
- Who owns GANX stock?
- 50 institutional investment managers reported GANX positions in their Form 13F filings for Q2 2026, holding 9,229,420 shares worth $18.6M in total. Marshall Wace, LLP reported the largest position.
- Are funds buying or selling GANX?
- In Q2 2026, 12 managers opened new GANX positions, 15 added, 9 trimmed and 4 sold out. Managers that filed in both quarters added a net 1,034,421 shares.
- How current is this GANX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to GANX by CUSIP. Options are left out. GANX news and filings · GANX insider trades · Top funds